121 related articles for article (PubMed ID: 15258697)
21. Near-diploid and near-triploid human sporadic colorectal adenocarcinomas differ for KRAS2 and TP53 mutational status.
Giaretti W; Venesio T; Sciutto A; Prevosto C; Geido E; Risio M
Genes Chromosomes Cancer; 2003 Jun; 37(2):207-13. PubMed ID: 12696070
[TBL] [Abstract][Full Text] [Related]
22. [Molecular genetic of ovarian cancer].
Yanaihara N; Okamoto A; Ochiai K; Tanaka T
Nihon Rinsho; 2012 Jun; 70 Suppl 4():475-9. PubMed ID: 23156293
[No Abstract] [Full Text] [Related]
23. Magnolin targeting of ERK1/2 inhibits cell proliferation and colony growth by induction of cellular senescence in ovarian cancer cells.
Song JH; Lee CJ; An HJ; Yoo SM; Kang HC; Lee JY; Kim KD; Kim DJ; Lee HS; Cho YY
Mol Carcinog; 2019 Jan; 58(1):88-101. PubMed ID: 30230030
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of the combination effect of wild-type TP53 gene transfection and cisplatin treatment for ovarian cancer xenografts.
Shimada M; Kigawa J; Kanamori Y; Itamochi H; Takahashi M; Kamazawa S; Sato S; Terakawa N
Eur J Cancer; 2000 Sep; 36(14):1869-75. PubMed ID: 10974636
[TBL] [Abstract][Full Text] [Related]
25. Polymorphisms in insulin-related genes predispose to specific KRAS2 and TP53 mutations in colon cancer.
Samowitz WS; Wolff RK; Ma KN; Andersen K; Caan B; Slattery ML
Mutat Res; 2006 Mar; 595(1-2):117-24. PubMed ID: 16448675
[TBL] [Abstract][Full Text] [Related]
26. Genotype-dependent radiosensitivity: clonogenic survival, apoptosis and cell-cycle redistribution.
Williams JR; Zhang Y; Zhou H; Russell J; Gridley DS; Koch CJ; Little JB
Int J Radiat Biol; 2008 Feb; 84(2):151-64. PubMed ID: 18246483
[TBL] [Abstract][Full Text] [Related]
27. Farnesyltransferase inhibitor (L-744,832) restores TGF-beta type II receptor expression and enhances radiation sensitivity in K-ras mutant pancreatic cancer cell line MIA PaCa-2.
Alcock RA; Dey S; Chendil D; Inayat MS; Mohiuddin M; Hartman G; Chatfield LK; Gallicchio VS; Ahmed MM
Oncogene; 2002 Nov; 21(51):7883-90. PubMed ID: 12420225
[TBL] [Abstract][Full Text] [Related]
28. The mutational profile of sporadic epithelial ovarian carcinoma.
Kalamanathan S; Bates V; Lord R; Green JA
Anticancer Res; 2011 Aug; 31(8):2661-8. PubMed ID: 21778320
[TBL] [Abstract][Full Text] [Related]
29. Regulation of BRCA1 and BRCA2 transcript in response to cisplatin, adriamycin, taxol and ionising radiation is correlated to p53 functional status in ovarian cancer cell lines.
Aunoble B; Bernard-Gallon D; Bignon YJ
Oncol Rep; 2001; 8(3):663-8. PubMed ID: 11295099
[TBL] [Abstract][Full Text] [Related]
30. Characterization of three new serous epithelial ovarian cancer cell lines.
Ouellet V; Zietarska M; Portelance L; Lafontaine J; Madore J; Puiffe ML; Arcand SL; Shen Z; Hébert J; Tonin PN; Provencher DM; Mes-Masson AM
BMC Cancer; 2008 May; 8():152. PubMed ID: 18507860
[TBL] [Abstract][Full Text] [Related]
31. Genetics and ovarian carcinoma.
Lynch HT; Casey MJ; Lynch J; White TE; Godwin AK
Semin Oncol; 1998 Jun; 25(3):265-80. PubMed ID: 9633840
[TBL] [Abstract][Full Text] [Related]
32. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53.
Ramirez PT; Gershenson DM; Tortolero-Luna G; Ramondetta LM; Fightmaster D; Wharton JT; Wolf JK
Gynecol Oncol; 2001 Dec; 83(3):543-8. PubMed ID: 11733969
[TBL] [Abstract][Full Text] [Related]
33. Human tumor cells segregate into radiosensitivity groups that associate with ATM and TP53 status.
Williams JR; Zhang Y; Russell J; Koch C; Little JB
Acta Oncol; 2007; 46(5):628-38. PubMed ID: 17562439
[TBL] [Abstract][Full Text] [Related]
34. Distinct sets of gene alterations in endometrial carcinoma implicate alternate modes of tumorigenesis.
Koul A; Willén R; Bendahl PO; Nilbert M; Borg A
Cancer; 2002 May; 94(9):2369-79. PubMed ID: 12015762
[TBL] [Abstract][Full Text] [Related]
35. An evaluation of cytotoxicity of the taxane and platinum agents combination treatment in a panel of human ovarian carcinoma cell lines.
Smith JA; Ngo H; Martin MC; Wolf JK
Gynecol Oncol; 2005 Jul; 98(1):141-5. PubMed ID: 15963813
[TBL] [Abstract][Full Text] [Related]
36. Small interfering RNA screens reveal enhanced cisplatin cytotoxicity in tumor cells having both BRCA network and TP53 disruptions.
Bartz SR; Zhang Z; Burchard J; Imakura M; Martin M; Palmieri A; Needham R; Guo J; Gordon M; Chung N; Warrener P; Jackson AL; Carleton M; Oatley M; Locco L; Santini F; Smith T; Kunapuli P; Ferrer M; Strulovici B; Friend SH; Linsley PS
Mol Cell Biol; 2006 Dec; 26(24):9377-86. PubMed ID: 17000754
[TBL] [Abstract][Full Text] [Related]
37. [Genetic abnormalities in the pathogenesis of ovarian cancer].
Yoshino K; Ueda Y; Kimura T; Kobayashi E; Fujita M; Enomoto T
Nihon Rinsho; 2012 Jun; 70 Suppl 4():480-7. PubMed ID: 23156294
[No Abstract] [Full Text] [Related]
38. Promoter methylation of TGFbeta receptor I and mutation of TGFbeta receptor II are frequent events in MSI sporadic gastric carcinomas.
Pinto M; Oliveira C; Cirnes L; Carlos Machado J; Ramires M; Nogueira A; Carneiro F; Seruca R
J Pathol; 2003 May; 200(1):32-8. PubMed ID: 12692838
[TBL] [Abstract][Full Text] [Related]
39. Ribosomal S6 kinase 4 (RSK4) expression in ovarian tumors and its regulation by antineoplastic drugs in ovarian cancer cell lines.
Arechavaleta-Velasco F; Zeferino-Toquero M; Estrada-Moscoso I; Imani-Razavi FS; Olivares A; Perez-Juarez CE; Diaz-Cueto L
Med Oncol; 2016 Feb; 33(2):11. PubMed ID: 26732474
[TBL] [Abstract][Full Text] [Related]
40. XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells.
Asselin E; Mills GB; Tsang BK
Cancer Res; 2001 Mar; 61(5):1862-8. PubMed ID: 11280739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
